Systemic Lupus Erythematosus Clinical Trials

1
Systemic Lupus Erythematosus Clinical Trials
Presented by Sun Research Institute
2
Introduction to SLE

• Definition SLE is an autoimmune disease where
  the immune system attacks the body's tissues,
  causing inflammation and damage.
• Symptoms Fatigue, joint pain, skin rashes, and
  organ damage.
• Prevalence Affects millions worldwide,
  predominantly women of childbearing age.

3

• Objective To develop new treatments, improve
  existing therapies, and understand disease
  mechanisms.

Importance of Clinical Trials

• Safety and Efficacy Ensures new treatments are
  safe and effective for SLE patients.

4
Phases of Clinical Trials

• Phase I
• Purpose Assess safety and dosage.
• Participants Small group of healthy volunteers
  or SLE patients.
• Phase II
• Purpose Evaluate efficacy and side effects.
• Participants Larger group of SLE patients.
• Phase III
• Purpose Confirm effectiveness, monitor side
  effects, and compare with standard treatments.
• Participants Large population of SLE patients.
• Phase IV
• Purpose Post-marketing surveillance to gather
  more information on risks and benefits.
• Participants General patient population.

5
Key Research Areas
01
02
03
04
Immunomodulatory Drugs
Biologics
Targeted Therapies
Lifestyle Interventions
6
Benefits of Participation

• Access to New Treatments Early access to
  cutting-edge therapies.
• Comprehensive Monitoring Detailed health
  assessments and monitoring.
• Contribution to Research Helping advance medical
  knowledge and future treatment options.

7
Consult Healthcare Providers
Advancing Care
How to Participate
Community Involvement
Online Registries
8
For more detailed information, visit
www.sunresearch.com Call 210-227-1289
9
Thank you very much!
www.sunresearch.com